Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020257
Abstract: Bedaquiline has been approved as a combination therapy to treat multi-drug-resistant tuberculosis in adults ≥ 18 years old. The citrate, fumarate, phosphate, and tartrate salts have obtained patents, but the structures for these moieties have…
read more here.
Keywords:
nicotinate;
benzoate hydrochloride;
characterization stability;
stability ... See more keywords